Skip to main content
Erschienen in: Clinical Rheumatology 2/2015

01.02.2015 | Original Article

Tailored approach to early psoriatic arthritis patients: clinical and ultrasonographic predictors for structural joint damage

verfasst von: Yasser El Miedany, Maha El Gaafary, Sally Youssef, Ihab Ahmed, Annie Nasr

Erschienen in: Clinical Rheumatology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

This study aims to identify the clinical predictors of arthritis in patients with psoriasis and to evaluate the use of musculoskeletal ultrasonography (US) as a predictor for inflammatory structural progression in psoriatic patients. Measures of association (odds ratio (OR)) were tested, in a prospective, cohort 1-year follow-up study, between structural deterioration and the presence of baseline inflammation, or its persistence. One hundred twenty-six psoriatic patients were prospectively evaluated both clinically and by US at 0, 6, and 12 months for synovitis/ joint damage, enthesitis, and onychopathy. X-ray was performed at 0 and 12 months. One hundred twelve sex and age-matched pasoriatic patients without histories of musculoskeletal symptoms were included as control group. Structural deterioration was observed in 47 % of the 5,292 evaluated joints. Clinical variables associated with arthritis risk: BMI > 25 (OR = 1.7), body surface area (OR = 1.13), family history (OR = 5.72) and nail involvement (OR = 2.25). BMI > 30 was significantly correlated (P < 0.01) with shorter time for the onset of arthritis. Baseline synovial score/PD score ≥ 2 was associated with increased risk of structural progression: OR = 1.98 versus 2.61 versus 2.66 (P < 0.001) for the clinical versus US-gray scale (GS) versus US-power Doppler (PD) evaluation, respectively. An increased probability for structural progression in the presence of enthesitis was observed (OR = 2.79 and 3.50) for both US-GS and US-PD, whereas OR was 2.46 for clinical examination. Onychopathy was associated with structural joint damage (OR = 2.30). In multivariate logistic regression analysis, persistent of synovitis/enthesitis at 6 months of therapy was predictive of subsequent structural progression. Family history of psoriatic arthritis, large BMI (>25), high percentage of psoriatic body surface area, and nail involvement were significantly associated with early onset psoriatic arthritis. Baseline GS score of ≥2, PD score of ≥2, presence of enthesitis, enhanced vascularity at enthesitis, higher GUESS score, and onychopathy, all at base line as well as persistent synovitis and enthesitis at 6 months are predictors of progressive early psoriatic arthritis. Regular ultrasonographic monitoring of these patients is mandatory to assess the progression of their arthritis status.
Literatur
1.
Zurück zum Zitat McHugh NJ, Balachrishnan C, Jones SM (2003) Progression of peripheral joint disease in psoriatic arthritis: a 5-year prospective study. Rheumatology (Oxford) 42:778–783CrossRef McHugh NJ, Balachrishnan C, Jones SM (2003) Progression of peripheral joint disease in psoriatic arthritis: a 5-year prospective study. Rheumatology (Oxford) 42:778–783CrossRef
2.
Zurück zum Zitat Gladman DD, Stafford-Brady F, Chang CH, Lewandowski K, Russell ML (1990) Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol 17:809–812PubMed Gladman DD, Stafford-Brady F, Chang CH, Lewandowski K, Russell ML (1990) Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol 17:809–812PubMed
3.
Zurück zum Zitat Torre Alonso JC, Rodriguez Perez A, Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez Larrea C (1991) Psoriatic arthritis (PA): a clinical and radiological study of 180 patients. Br J Rheumatol 30:245–250PubMedCrossRef Torre Alonso JC, Rodriguez Perez A, Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez Larrea C (1991) Psoriatic arthritis (PA): a clinical and radiological study of 180 patients. Br J Rheumatol 30:245–250PubMedCrossRef
4.
Zurück zum Zitat Kane D, Stafford L, Bresnihan B, FitzGerald O (2003) A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 42:1460–1468CrossRef Kane D, Stafford L, Bresnihan B, FitzGerald O (2003) A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 42:1460–1468CrossRef
5.
Zurück zum Zitat Gladman DD, Farewell VT, Wong K, Husted J (1998) Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41:1103–1110PubMedCrossRef Gladman DD, Farewell VT, Wong K, Husted J (1998) Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41:1103–1110PubMedCrossRef
6.
Zurück zum Zitat Gladman DD (2005) Disability and quality of life considerations. Psoriatic arthritis. In: Gordon GB, Ruderman E (eds) Psoriasis and psoriatic arthritis: an integrated approach. Springer- Verlag, Heidelberg, pp 118–123CrossRef Gladman DD (2005) Disability and quality of life considerations. Psoriatic arthritis. In: Gordon GB, Ruderman E (eds) Psoriasis and psoriatic arthritis: an integrated approach. Springer- Verlag, Heidelberg, pp 118–123CrossRef
7.
Zurück zum Zitat Bandinelli F, Prignano F, Bonciani D, Pallanti S, Lotti T, Giovannini L, Maddali Bongi S, Matucci Cerinic M (2013) Clinical and socio-demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA). Clin Exp Rheumatol 31:0318–0319 Bandinelli F, Prignano F, Bonciani D, Pallanti S, Lotti T, Giovannini L, Maddali Bongi S, Matucci Cerinic M (2013) Clinical and socio-demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA). Clin Exp Rheumatol 31:0318–0319
8.
Zurück zum Zitat Kavanaugh AF, Ritchlin CT (2006) and the GRAPPA Treatment Guideline Committee. Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines. J Rheumatol 33:1417–1421PubMed Kavanaugh AF, Ritchlin CT (2006) and the GRAPPA Treatment Guideline Committee. Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines. J Rheumatol 33:1417–1421PubMed
9.
Zurück zum Zitat Mease PJ, Kivitz AJ, Burch FX et al (2004) Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 50:2264–2272PubMedCrossRef Mease PJ, Kivitz AJ, Burch FX et al (2004) Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 50:2264–2272PubMedCrossRef
10.
Zurück zum Zitat Kavanaugh A, Antoni CE, Gladman D et al (2006) The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year. Ann Rheum Dis 65:1038–1043PubMedCentralPubMedCrossRef Kavanaugh A, Antoni CE, Gladman D et al (2006) The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year. Ann Rheum Dis 65:1038–1043PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Mease PJ, Gladman DD, Ritchlin CT et al (2005) Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 52:3279–3289PubMedCrossRef Mease PJ, Gladman DD, Ritchlin CT et al (2005) Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 52:3279–3289PubMedCrossRef
12.
Zurück zum Zitat McInnes I, Kavanaugh A, Gottlieb A et al (2013) Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicenter, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet 382(9894):780–789PubMedCrossRef McInnes I, Kavanaugh A, Gottlieb A et al (2013) Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicenter, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet 382(9894):780–789PubMedCrossRef
13.
Zurück zum Zitat Salvarani C, Olivieri I, Pipitone N et al (2006) Recommendations of the Italian Society for Rheumatology for the use of biologic (TNFalpha blocking) agents in the treatment of psoriatic arthritis. ClinExpRheumatol 24:70–78 Salvarani C, Olivieri I, Pipitone N et al (2006) Recommendations of the Italian Society for Rheumatology for the use of biologic (TNFalpha blocking) agents in the treatment of psoriatic arthritis. ClinExpRheumatol 24:70–78
14.
Zurück zum Zitat Salvarani C, Cantini F, Olivieri I et al (1997) Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis. J Rheumatol 24:1106–1110PubMed Salvarani C, Cantini F, Olivieri I et al (1997) Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis. J Rheumatol 24:1106–1110PubMed
15.
Zurück zum Zitat Jones SM, Armas JB, Cohen MG et al (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33:834–839PubMedCrossRef Jones SM, Armas JB, Cohen MG et al (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33:834–839PubMedCrossRef
16.
Zurück zum Zitat Gladman DD, Shuckett R, Russell ML et al (1987) Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med 62:127–141PubMed Gladman DD, Shuckett R, Russell ML et al (1987) Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med 62:127–141PubMed
17.
Zurück zum Zitat McGonagle D, Ash Z, Dickie L, McDermott M, Aydin SZ (2011) The early phase of pasoriatic arthritis. Ann Rheum Dis 70(Suppl 1):i71–i76PubMedCrossRef McGonagle D, Ash Z, Dickie L, McDermott M, Aydin SZ (2011) The early phase of pasoriatic arthritis. Ann Rheum Dis 70(Suppl 1):i71–i76PubMedCrossRef
19.
Zurück zum Zitat Wiell C et al (2007) Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res Ther 9:R119PubMedCentralPubMedCrossRef Wiell C et al (2007) Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res Ther 9:R119PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Peloso PM, Behl M, Hull P, Reeder B (1997) The psoriasis and arthritis questionnaire (PAQ) in detection of arthritis among patients with psoriasis. Arthritis Rheum 40(Suppl):S64 Peloso PM, Behl M, Hull P, Reeder B (1997) The psoriasis and arthritis questionnaire (PAQ) in detection of arthritis among patients with psoriasis. Arthritis Rheum 40(Suppl):S64
21.
Zurück zum Zitat Gladman DD et al (2009) Development and initial validation of a screening questionnaire for psoriatic arthritis: The Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 68:497–501PubMedCrossRef Gladman DD et al (2009) Development and initial validation of a screening questionnaire for psoriatic arthritis: The Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 68:497–501PubMedCrossRef
22.
Zurück zum Zitat El Miedany Y, El Gaafary M, Youssef S, Palmer D (2010) Towards a multidimensional patient reported outcome measures assessment: development and validation of a questionnaire for patients with ankylosing spondylitis/spondyloarthritis. Joint Bone Spine 77(6):575–581PubMedCrossRef El Miedany Y, El Gaafary M, Youssef S, Palmer D (2010) Towards a multidimensional patient reported outcome measures assessment: development and validation of a questionnaire for patients with ankylosing spondylitis/spondyloarthritis. Joint Bone Spine 77(6):575–581PubMedCrossRef
23.
Zurück zum Zitat Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673PubMedCrossRef Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673PubMedCrossRef
24.
Zurück zum Zitat Fernández-Espartero C, de Miguel E, Loza E et al. Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Ann Rheum Dis doi:10.1136/annrheumdis-2012-202976 Fernández-Espartero C, de Miguel E, Loza E et al. Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Ann Rheum Dis doi:10.​1136/​annrheumdis-2012-202976
25.
26.
Zurück zum Zitat Sharp JT, Lidsky MD, Collins LC, Moreland J (1971) Method of scoring the progression of radiologic changes in rheumatoid arthritis. Arthritis Rheum 14:706–720PubMedCrossRef Sharp JT, Lidsky MD, Collins LC, Moreland J (1971) Method of scoring the progression of radiologic changes in rheumatoid arthritis. Arthritis Rheum 14:706–720PubMedCrossRef
27.
Zurück zum Zitat Sharp JT, Young DY, Bluhm GP et al (1985) How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 28:1326–1335PubMedCrossRef Sharp JT, Young DY, Bluhm GP et al (1985) How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 28:1326–1335PubMedCrossRef
28.
Zurück zum Zitat Bennet PH, Burch TA (1967) New York Symposium of population studies in rheumatic diseases: new diagnostic criteria. Bull Rheum Dis 17:453–458 Bennet PH, Burch TA (1967) New York Symposium of population studies in rheumatic diseases: new diagnostic criteria. Bull Rheum Dis 17:453–458
30.
Zurück zum Zitat Szkudlarek M, Court-Payen A, Strandberb C (2001) Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging. Arthritis Rheum 44:2018–2023PubMedCrossRef Szkudlarek M, Court-Payen A, Strandberb C (2001) Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging. Arthritis Rheum 44:2018–2023PubMedCrossRef
31.
Zurück zum Zitat Balint PV, Kane D, Wilson H, McInnes IB, Sturrock RD (2002) Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 61:905–910PubMedCentralPubMedCrossRef Balint PV, Kane D, Wilson H, McInnes IB, Sturrock RD (2002) Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 61:905–910PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Bandinelli F, Prignano F, Bonciani D et al (2013) Ultrasound detects occult entheseal involvement in early psoriatic arthritis independently of clinical features and psoriasis severity. Clin Exp Rheumatol 31:0219–0224 Bandinelli F, Prignano F, Bonciani D et al (2013) Ultrasound detects occult entheseal involvement in early psoriatic arthritis independently of clinical features and psoriasis severity. Clin Exp Rheumatol 31:0219–0224
34.
Zurück zum Zitat Husted JA, Tom BD, Farewell VT (2007) e t al. A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: does the effect change over time? Arthritis Rheum 56:840–849PubMedCrossRef Husted JA, Tom BD, Farewell VT (2007) e t al. A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: does the effect change over time? Arthritis Rheum 56:840–849PubMedCrossRef
35.
Zurück zum Zitat Gladman DD, Farewell VT, Wong K (1998) e t al. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41:1103–1110PubMedCrossRef Gladman DD, Farewell VT, Wong K (1998) e t al. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41:1103–1110PubMedCrossRef
37.
Zurück zum Zitat Bandinelli F, Bonacci E, Matucci M (2013) Ultrasound-integrated tight control in early psoriatic arthritis (PsA) during Adalimumab treatment. Clin Exp Rheumatol 31:440–442PubMed Bandinelli F, Bonacci E, Matucci M (2013) Ultrasound-integrated tight control in early psoriatic arthritis (PsA) during Adalimumab treatment. Clin Exp Rheumatol 31:440–442PubMed
38.
Zurück zum Zitat Witt M, Mueller F, Nigg A et al (2013) Relevance of grade 1 gray-scale ultrasound findings in wrists and small joints to the assessment of subclinical synovitis in rheumatoid arthritis. Arthritis Rheum 65(7):1694–1701PubMedCrossRef Witt M, Mueller F, Nigg A et al (2013) Relevance of grade 1 gray-scale ultrasound findings in wrists and small joints to the assessment of subclinical synovitis in rheumatoid arthritis. Arthritis Rheum 65(7):1694–1701PubMedCrossRef
39.
Zurück zum Zitat Scott DL, Antoni C, Choy EH, van Riel PC (2003) Joint counts in routine practice [editorial]. Rheumatology (Oxford) 42:919–923CrossRef Scott DL, Antoni C, Choy EH, van Riel PC (2003) Joint counts in routine practice [editorial]. Rheumatology (Oxford) 42:919–923CrossRef
40.
Zurück zum Zitat Van der Heijde DM, van 't Hof M, Van Riel PL, van de Putte LB (1993) Validity of single variables and indices to measure disease activity in rheumatoid arthritis. J Rheumatol 20:538–541PubMed Van der Heijde DM, van 't Hof M, Van Riel PL, van de Putte LB (1993) Validity of single variables and indices to measure disease activity in rheumatoid arthritis. J Rheumatol 20:538–541PubMed
41.
Zurück zum Zitat Hart LE, Tugwell P, Buchanan WW, Norman GR, Grace EM, Southwell D (1985) Grading of tenderness as a source of interrater error in the Ritchie articular index. J Rheumatol 12:716–717PubMed Hart LE, Tugwell P, Buchanan WW, Norman GR, Grace EM, Southwell D (1985) Grading of tenderness as a source of interrater error in the Ritchie articular index. J Rheumatol 12:716–717PubMed
42.
Zurück zum Zitat Grunke M, Antoni CE, Kavanaugh A, Hildebrand V, Dechant C, Schett G (2010) etal. Standardization of joint examination technique leads to a significant decrease in variability among different examiners. J Rheumatol 37:860–864PubMedCrossRef Grunke M, Antoni CE, Kavanaugh A, Hildebrand V, Dechant C, Schett G (2010) etal. Standardization of joint examination technique leads to a significant decrease in variability among different examiners. J Rheumatol 37:860–864PubMedCrossRef
43.
Zurück zum Zitat Taylor W et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673PubMedCrossRef Taylor W et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673PubMedCrossRef
44.
Zurück zum Zitat Chandran V et al (2009) Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Care Res 57:1560–1563CrossRef Chandran V et al (2009) Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Care Res 57:1560–1563CrossRef
45.
Zurück zum Zitat D'Angelo S et al (2009) Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J Rheumatol 36:368–370PubMedCrossRef D'Angelo S et al (2009) Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J Rheumatol 36:368–370PubMedCrossRef
46.
Zurück zum Zitat Williamson L, Dalbeth N, Dockerty J et al (2004) Nail disease in psoriatic arthritis—clinically important, potentially treatable and often overlooked. Rheumatology 43:790–794PubMedCrossRef Williamson L, Dalbeth N, Dockerty J et al (2004) Nail disease in psoriatic arthritis—clinically important, potentially treatable and often overlooked. Rheumatology 43:790–794PubMedCrossRef
47.
Zurück zum Zitat Wilson FC, Icen M, Crowson CS et al (2009) Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 61:233–239PubMedCentralPubMedCrossRef Wilson FC, Icen M, Crowson CS et al (2009) Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 61:233–239PubMedCentralPubMedCrossRef
48.
Zurück zum Zitat McGonaglea D, Benjaminb M, Lyn TA (2009) The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all? Curr Opin Rheumatol 21:340–347CrossRef McGonaglea D, Benjaminb M, Lyn TA (2009) The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all? Curr Opin Rheumatol 21:340–347CrossRef
49.
Zurück zum Zitat Tan AL, Benjamin M, Toumi H et al (2007) The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis: a high-resolution MRI and histological study. Rheumatology (Oxford) 46:253–256CrossRef Tan AL, Benjamin M, Toumi H et al (2007) The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis: a high-resolution MRI and histological study. Rheumatology (Oxford) 46:253–256CrossRef
Metadaten
Titel
Tailored approach to early psoriatic arthritis patients: clinical and ultrasonographic predictors for structural joint damage
verfasst von
Yasser El Miedany
Maha El Gaafary
Sally Youssef
Ihab Ahmed
Annie Nasr
Publikationsdatum
01.02.2015
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 2/2015
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2630-2

Weitere Artikel der Ausgabe 2/2015

Clinical Rheumatology 2/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.